Paperpal Prime Logo

Drugs and Aging : Impact Factor & More

eISSN: 1179-1969pISSN: 1170-229X

Aims and Scope of Drugs and Aging

Drugs & Aging is a monthly peer-reviewed medical journal published by Springer Nature under their Adis International imprint. It contains primarily review articles covering optimum use of drug therapies in older adults. Less

Key Metrics

CiteScore
6.7
Eigenfactor
0.001 - 0.005
H-Index
103
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.58
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Drugs and Aging

Drugs and Aging Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Drugs and Aging ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drugs and Aging

Clinical and Economic Outcomes of Korea's National Polypharmacy Management Program for Hospitalized Older Adults: 90-Day Readmission and Healthcare Costs.
  • 8 Aug 2026
  • Drugs & aging
Body Mass Index Category and the Association Between Polypharmacy and Functional Recovery in Stroke Patients: A Retrospective Cohort Study.
  • 4 Aug 2026
  • Drugs & aging
Bipolar Disorder in Older Adults: A Comprehensive Overview of Pharmacotherapy Patterns and Clinical Considerations.
  • 1 Aug 2026
  • Drugs & aging
Pharmacologic Treatment for Obstructive Sleep Apnea in Older Adults.
  • 1 Aug 2026
  • Drugs & aging
Impact of Age on Bleeding, Stroke, and Mortality in Edoxaban-Treated Patients with Atrial Fibrillation: Results from the ETAF-TR Registry.
  • 1 Aug 2026
  • Drugs & aging
Gabapentinoid Use and Risk of Alzheimer's Disease-Related Dementias: A Systematic Review and Meta-analysis of Observational Studies.
  • 1 Aug 2026
  • Drugs & aging
Clinical and Economic Outcomes of Korea's National Polypharmacy Management Program for Hospitalized Older Adults: 90-Day Readmission and Healthcare Costs.
  • 8 Aug 2026
  • Drugs & aging
Body Mass Index Category and the Association Between Polypharmacy and Functional Recovery in Stroke Patients: A Retrospective Cohort Study.
  • 4 Aug 2026
  • Drugs & aging
Bipolar Disorder in Older Adults: A Comprehensive Overview of Pharmacotherapy Patterns and Clinical Considerations.
  • 1 Aug 2026
  • Drugs & aging
Pharmacologic Treatment for Obstructive Sleep Apnea in Older Adults.
  • 1 Aug 2026
  • Drugs & aging
Impact of Age on Bleeding, Stroke, and Mortality in Edoxaban-Treated Patients with Atrial Fibrillation: Results from the ETAF-TR Registry.
  • 1 Aug 2026
  • Drugs & aging
Gabapentinoid Use and Risk of Alzheimer's Disease-Related Dementias: A Systematic Review and Meta-analysis of Observational Studies.
  • 1 Aug 2026
  • Drugs & aging

FAQs on Drugs and Aging